← Browse by Condition
Medical Condition
uc ulcerative colitis
Total Trials
3
Recruiting Now
3
Trial Phases
Phase 2
NCT06850727 Phase 2
Recruiting
Safety and Efficacy of OD-07656 and of Subsequent Vedolizumab Therapy in Moderately to Severely Active Ulcerative Colitis
Enrollment
57 pts
Location
Australia, Austria, ...
Sponsor
Odyssey Therapeutics
NCT07089420
Recruiting
ALPCO/Calprotectin CLIA Assay: Expected Values of Calprotectin in Healthy Subjects
Enrollment
120 pts
Location
United States
Sponsor
American Laboratory Products C...
NCT07035041 Phase 2
Recruiting
A Phase 2 Study of D-2570 in Subjects With Moderately to Severely Active Ulcerative Colitis
Enrollment
120 pts
Location
China
Sponsor
InventisBio Co., Ltd